Kršek, A. & Batičić, L. (2024). Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease. Future Pharmacology, 4. (2), 352-379. doi: 10.3390/futurepharmacol4020020
Kršek, Antea and Lara Batičić. "Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease." Future Pharmacology, vol. 4, no. 2, 2024, pp. 352-379. https://doi.org/10.3390/futurepharmacol4020020
Kršek, Antea and Lara Batičić. "Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease." Future Pharmacology 4, no. 2 (2024): 352-379. https://doi.org/10.3390/futurepharmacol4020020
Kršek, A. and Batičić, L. (2024) 'Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease', Future Pharmacology, 4(2), pp. 352-379. doi: 10.3390/futurepharmacol4020020
Kršek A, Batičić L. Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease. Future Pharmacology [Internet]. 2024 April 30 [cited 2024 August 26];4(2):352-379. doi: 10.3390/futurepharmacol4020020
A. Kršek and L. Batičić, "Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease", Future Pharmacology, vol. 4, no. 2, pp. 352-379, April 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:926704. [Accessed: 26 August 2024]